The observation that this is enhanced when receptor signaling is blocked suggests that other pathways are activated in the tumor cells or that effects of TGFβ1 on the tumor microenvironment predominate, where elevated TGFβ1 leads to significant inflammation. The gene discussed is TGFB1; the disease is neoplasm.